Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 213.40M | £ 157.40M | £ 131.10M | £ 134.10M | £ 125.50M |
Total Assets | £ 2.74B | £ 2.20B | £ 2.01B | £ 1.88B | £ 1.88B |
Total Debt | £ 713.00M | £ 432.20M | £ 411.30M | £ 390.30M | £ 440.50M |
Net Debt | £ 499.60M | £ 274.80M | £ 280.20M | £ 256.20M | £ 315.00M |
Total Liabilities | £ 1.11B | £ 793.90M | £ 736.10M | £ 710.30M | £ 759.20M |
Stockholders Equity | £ 1.63B | £ 1.40B | £ 1.28B | £ 1.17B | £ 1.12B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |